Vytorin makers say cancer results likely an anomaly (Reuters)

[riky]

Vytorin makers say cancer results likely an anomaly
    (Reuters)

 


Reuters - Cancer findings in a new study of
cholesterol drug Vytorin are "likely to be an anomaly"
unrelated to the drug, makers Merck & Co and Schering-Plough
Corp said in a letter to doctors.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080723/hl_nm/merck_scheringplough_vytorin_dc